Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Insight Genetics Promotes Four

Published: Wednesday, February 13, 2013
Last Updated: Wednesday, February 13, 2013
Bookmark and Share
Molecular diagnostics company builds expertise and depth in research, application and commercial development of companion diagnostics to improve cancer care.

Insight Genetics has announced that it has promoted four of its team members:
• Brock Schweitzer, PhD, is now senior scientist;
• Rachel Skelton, PhD, was promoted to regulatory scientist I;
• Kasey Lawrence was named technology specialist; and
• JonEric Pettersson assumed a new role as manager of commercial development.

Since its founding in 2007, Insight Genetics has been dedicated to enabling precision medicine in cancer care. The company collaborates with researchers, clinicians, and drug developers to develop molecular diagnostics that aid physicians in precisely typing and effectively treating patients’ cancers.

“Brock, Rachel, Kasey and JonEric have brought a breadth of knowledge and expertise to Insight Genetics that has helped us consistently generate exceptional scientific results and inform our business development efforts,” said Christopher Callaghan, president and COO of Insight Genetics. “They have all made significant contributions to our company’s growth and been integral in advancing the field of personalized cancer care.”

Senior Scientist Schweitzer, who completed his post-doctoral research training in immune cell function at Vanderbilt University School of Medicine, plans and conducts laboratory research on Insight Genetics’ expanding array of diagnostic tests.

He also contributes to the company’s licensing of biomarkers and technologies, and supports planning and coordination of its academic, clinical and corporate partnerships.

Before joining Insight Genetics as scientist II in 2012, Schweitzer received his PhD in molecular genetics from University of Cincinnati College of Medicine.

As regulatory scientist I, Skelton works with clinicians, researchers and pharmaceutical companies to test patient samples for cancer-causing biomarkers within Insight Genetics’ CLIA-certified molecular diagnostic lab.

She also ensures scientific and regulatory compliance for all tests performed in the lab. Skelton joined Insight Genetics in July 2012 after receiving her PhD in cell and developmental biology from Vanderbilt University School of Medicine, where she became proficient in molecular diagnostics and genetic screening.

As a technology specialist, Lawrence oversees day-to-day operations and conducts research for clinical tests in development, while also managing data in the CLIA lab.

As in his previous role as research associate III, Lawrence will continue to use his research background to apply new techniques and technologies in the company’s diagnostic lab.

Prior to joining Insight Genetics, Lawrence worked as a research assistant at Vanderbilt University’s Division of Genetic Medicine and the Genome Sciences Resource. He holds a bachelor of science in biology from Tennessee Tech University.

Pettersson, as manager of commercial development, guides commercialization of the company’s products for cancer diagnosis and monitoring. He also will identify new diagnostic and partnership opportunities for Insight Genetics.

Pettersson joined Insight Genetics in 2007 and became the company’s senior associate of business development in 2011.

He holds a bachelor’s degree in business administration, with a focus on international business, from Belmont University.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos